1. Home
  2. VIR vs NN Comparison

VIR vs NN Comparison

Compare VIR & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • NN
  • Stock Information
  • Founded
  • VIR 2016
  • NN 2007
  • Country
  • VIR United States
  • NN United States
  • Employees
  • VIR N/A
  • NN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • NN Industrial Machinery/Components
  • Sector
  • VIR Health Care
  • NN Industrials
  • Exchange
  • VIR Nasdaq
  • NN Nasdaq
  • Market Cap
  • VIR 1.4B
  • NN 1.4B
  • IPO Year
  • VIR 2019
  • NN N/A
  • Fundamental
  • Price
  • VIR $7.00
  • NN $11.20
  • Analyst Decision
  • VIR Buy
  • NN
  • Analyst Count
  • VIR 6
  • NN 0
  • Target Price
  • VIR $35.67
  • NN N/A
  • AVG Volume (30 Days)
  • VIR 1.2M
  • NN 1.3M
  • Earning Date
  • VIR 05-01-2025
  • NN 03-12-2025
  • Dividend Yield
  • VIR N/A
  • NN N/A
  • EPS Growth
  • VIR N/A
  • NN N/A
  • EPS
  • VIR N/A
  • NN N/A
  • Revenue
  • VIR $74,205,000.00
  • NN $5,669,000.00
  • Revenue This Year
  • VIR N/A
  • NN $46.32
  • Revenue Next Year
  • VIR $17.69
  • NN $43.50
  • P/E Ratio
  • VIR N/A
  • NN N/A
  • Revenue Growth
  • VIR N/A
  • NN 46.79
  • 52 Week Low
  • VIR $6.56
  • NN $3.95
  • 52 Week High
  • VIR $14.45
  • NN $18.54
  • Technical
  • Relative Strength Index (RSI)
  • VIR 28.28
  • NN 49.44
  • Support Level
  • VIR $6.96
  • NN $9.90
  • Resistance Level
  • VIR $7.46
  • NN $10.93
  • Average True Range (ATR)
  • VIR 0.57
  • NN 1.06
  • MACD
  • VIR -0.16
  • NN 0.09
  • Stochastic Oscillator
  • VIR 1.56
  • NN 60.34

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.

Share on Social Networks: